Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Organ Transplantation Immunosuppressive Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Organ Transplantation Immunosuppressive Drugmarket, defines the market attractiveness level of Organ Transplantation Immunosuppressive Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Organ Transplantation Immunosuppressive Drug industry, describes the types of Organ Transplantation Immunosuppressive Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Organ Transplantation Immunosuppressive Drug market and the development prospects and opportunities of Organ Transplantation Immunosuppressive Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Organ Transplantation Immunosuppressive Drug market in Chapter 13.
By Player:
Allergan Plc
GlaxoSmithKline plc
Pfizer
Astellas Pharma
Veloxis Pharmaceuticals A/S
Novartis AG
Roche
Sanofi SA
Bristol-Myers Squibb Company
AbbVie
By Type:
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
By End-User:
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Organ Transplantation Immunosuppressive Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Organ Transplantation Immunosuppressive Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Organ Transplantation Immunosuppressive Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Organ Transplantation Immunosuppressive Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Organ Transplantation Immunosuppressive Drug Market Analysis and Outlook to 2022
-
7.1 Global Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
7.2 United States Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
7.3 Europe Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
7.4 China Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
7.5 Japan Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
7.6 India Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
7.7 South Korea Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
8 Region and Country-wise Organ Transplantation Immunosuppressive Drug Market Analysis and Outlook to 2028
-
8.1 Global Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
8.2 United States Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
8.3 Europe Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
8.4 China Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
8.5 Japan Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
8.6 India Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
9 Global Organ Transplantation Immunosuppressive Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiproliferative Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Steroids Consumption and Growth Rate (2017-2022)
-
9.2 Global Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Kidney Transplant Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Liver Transplant Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Heart Transplant Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Lungs Transplant Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Transplant Consumption and Growth Rate (2017-2022)
10 Global Organ Transplantation Immunosuppressive Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiproliferative Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Kidney Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Liver Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Heart Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Lungs Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Transplant Consumption Forecast and Growth Rate (2022-2028)
11 Global Organ Transplantation Immunosuppressive Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Organ Transplantation Immunosuppressive Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Organ Transplantation Immunosuppressive Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Organ Transplantation Immunosuppressive Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Organ Transplantation Immunosuppressive Drug Market Competitive Analysis
-
14.1 Allergan Plc
-
14.1.1 Allergan Plc Company Details
-
14.1.2 Allergan Plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan Plc Organ Transplantation Immunosuppressive Drug Product and Service
-
14.2 GlaxoSmithKline plc
-
14.2.1 GlaxoSmithKline plc Company Details
-
14.2.2 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Organ Transplantation Immunosuppressive Drug Product and Service
-
14.4 Astellas Pharma
-
14.4.1 Astellas Pharma Company Details
-
14.4.2 Astellas Pharma Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Astellas Pharma Organ Transplantation Immunosuppressive Drug Product and Service
-
14.5 Veloxis Pharmaceuticals A/S
-
14.5.1 Veloxis Pharmaceuticals A/S Company Details
-
14.5.2 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product and Service
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Details
-
14.6.2 Novartis AG Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis AG Organ Transplantation Immunosuppressive Drug Product and Service
-
14.7 Roche
-
14.7.1 Roche Company Details
-
14.7.2 Roche Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Roche Organ Transplantation Immunosuppressive Drug Product and Service
-
14.8 Sanofi SA
-
14.8.1 Sanofi SA Company Details
-
14.8.2 Sanofi SA Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi SA Organ Transplantation Immunosuppressive Drug Product and Service
-
14.9 Bristol-Myers Squibb Company
-
14.9.1 Bristol-Myers Squibb Company Company Details
-
14.9.2 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product and Service
-
14.10 AbbVie
-
14.10.1 AbbVie Company Details
-
14.10.2 AbbVie Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AbbVie Organ Transplantation Immunosuppressive Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Organ Transplantation Immunosuppressive Drug
-
Figure Organ Transplantation Immunosuppressive Drug Picture
-
Table Global Organ Transplantation Immunosuppressive Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Organ Transplantation Immunosuppressive Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Organ Transplantation Immunosuppressive Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure United States Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure China Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure India Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Antiproliferative Agents Consumption and Growth Rate (2017-2022)
-
Figure Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Steroids Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Lungs Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Others Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiproliferative Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lungs Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Organ Transplantation Immunosuppressive Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Organ Transplantation Immunosuppressive Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan Plc (Foundation Year, Company Profile and etc.)
-
Table Allergan Plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Plc Organ Transplantation Immunosuppressive Drug Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Veloxis Pharmaceuticals A/S (Foundation Year, Company Profile and etc.)
-
Table Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Organ Transplantation Immunosuppressive Drug Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Organ Transplantation Immunosuppressive Drug Product and Service
-
